Clinical data, simply

studies delivered

site users

patients

Trusted by over 1,000 clients globally

CRScube is at the forefront of clinical data management.

Dedicated to empowering the pharmaceutical, biotechnology and medical device industries, we’re advancing technology and enhancing research efficiency.

Join us on a journey as we push the boundaries of what’s possible – and advance clinical trials together.

Transforming your trials

Designed with your needs in mind, our unified suite of solutions simplifies your processes, helping accelerate research, improve data quality, and drive impactful results.

Our solutions

Supporting your medical breakthroughs

Streamline trials, boost ROI

Maximize value, minimize risks

Enhance your competitive edge

Clean, accurate data at your fingertips

One platform, multiple solutions

Affordable, scalable solutions

Experience CRScube

Book a demo

Your clinical research ally

From study design to data analysis, we’ve got you covered thanks to end-to-end support.

Our services

Empowering progress: our story

We are dedicated to developing impactful solutions that reshape trial management, enhance site operations, and improve patient experiences.

Our company

CRScube is widely recognized as a leader in the industry

The good thing about CRScube is that they listen carefully to user requests and quickly provide optimal solutions. It has helped me many times in the past during setup phase.

Hideyuki F.

Clinical Database Programmer

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

Electronic safety reporting in clinical trials: What sponsors need to know

For sponsors and CROs, it is crucial to understand the implications of the full enforcement of ICH E2B(R3) standards, especially as it impacts both pre- and post-authorization submissions.

From our sales leaders Juan Munoz-Pujol and Scott Robertson

Why ICH E2B(R3) still matters in 2026 – A conversation with Ducksang (David) Im

While E2B(R3) standard has existed for some time, global adoption has been gradual. What makes 2026 critical is that many regulatory authorities worldwide have now finalized mandatory transitions.

See CRScube in action